Austin Heart, a provider of cardiac and vascular services, has started enrolling peripheral arterial disease (PAD) patients for Avinger's Connect II trial. The multi-center, non-randomized and prospective trial is designed to evaluate ...
Tags: Austin Heart, PAD patients, Connect II trial, peripheral arterial disease
IDEV Technologies, a developer of peripheral vascular devices, has introduced SurePath Guidewires in the US. The SurePath Guidewires are designed for use in peripheral and coronary procedures and its proprietary alloy provides good kink ...
Tags: IDEV, SurePath Guidewires, cardiology